Koenig, Wolfgang (19..-....)
KOENIG Wolfgang, Ulm, GER<br>Wolfgang Koenig, MD, PhD, FRCP, FESC, FACC, FAHA is a Professor of Medicine and Cardiology at the University of Ulm Medical School, Ulm, Germany. He is Board certified in internal medicine, cardiology, and in intensive care medicine with special interest in invasive and interventional cardiology. At present he serves as a Consultant in Cardiology, and is the Director of the Preventive Cardiology Program and the Clinical Trial Unit (CTU) at the Department of Internal Medicine II - Cardiology of the University of Ulm Medical Center.
Dr. Koenig`s research interests involve the molecular basis of atherothrombogenesis including genomics, metabolomics, and other technologies. Further interests include type 2 diabetes, the metabolic syndrome, the clinical pharmacology of cardiovascular active compounds, and the clinical epidemiology of cardiovascular disorders, focusing on the identification and evaluation of new biomarkers for cardiometabolic diseases. Dr. Koenig has published more than 500 research papers and reviews. He has an H-Index of 60. He is a member of the Editorial Board of Clinical Chemistry and Associate Editor of Atherosclerosis. Presently he serves on the Steering Committee of various large international randomized clinical trials testing innovative targets in cardiovascular medicine.
Vidéos
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 2 : Well Established Methods…
MODIGLIANI Workshop 2 - Friday November 30, 2012 : ATHEROSCLEROSIS IMAGING IN CLINICAL TRIALS Facilitating the discovery of effective therapies Chairpersons: Jagat NARULA, New York, USA - Ahmed
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Identifying new targets:…
Will new compounds be able to reduce the residual risk in high risk patients when treatment targets based on new ESC guidelines have been achieved (e.g. LDL-C lesser than 70mg/dl)?
Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Target populations: How do we risk-st…
Title : Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Target populations: How do we risk-stratify? Are additional biomarkers helpful? Speaker: Wolfgang KOENIG, Ulm, GER Discussant: